Regenerative Medicines for Remyelination: From Aspiration to Reality
- PMID: 26046755
- DOI: 10.1016/j.stem.2015.05.010
Regenerative Medicines for Remyelination: From Aspiration to Reality
Abstract
Stimulating an endogenous regenerative response is a powerful approach for potential treatment of chronic demyelinating diseases such as multiple sclerosis. Recently in Nature, Najm et al. (2015) identified two clinically relevant, FDA-approved compounds that promote oligodendrocyte progenitor cell differentiation and induce remyelination in demyelinating disease models.
Copyright © 2015 Elsevier Inc. All rights reserved.
Comment on
-
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.Nature. 2015 Jun 11;522(7555):216-20. doi: 10.1038/nature14335. Epub 2015 Apr 20. Nature. 2015. PMID: 25896324 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical